Effects of High-Dose Atorvastatin on Cerebrovascular Events in Patients With Stable Coronary Disease in the TNT (Treating to New Targets) Study
David D. Waters, MD, FACC*, , , ,||,¶,#,1,*,
John C. LaRosa, MD*, , , ,||,¶,#,2,
Philip Barter, MD*, , , ,||,¶,#,3,
Jean-Charles Fruchart, PhD*, , , ,||,¶,#,4,
Antonio M. Gotto, Jr, MD, DPhil, FACC*, , , ,||,¶,#,5,
Roddy Carter, MD*, , , ,||,¶,#,6,
Andrei Breazna, PhD*, , , ,||,¶,#,6,
John J.P. Kastelein, MD, PhD*, , , ,||,¶,#,7 and
Scott M. Grundy, MD, PhD*, , , ,||,¶,#,8
* University of California, San Francisco, California
State University of New York Health Science Center, New York, New York
Heart Research Institute, Sydney, Australia
Institut Pasteur, Lille, France
|| Weil Medical College of Cornell University, New York, New York
¶ Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
# University of Texas Southwestern Medical Center, Dallas, Texas
|